Along with the Indonesian Ministry of Health and Indonesian Pediatrician Association (IDAI), Novo Nordisk and its global partners are targeting to cover three thousand children and adolescents with diabetes in the first phase of this program by utilizing 20 clinics with improved health facilities and assisted by one thousand trained health workers.
"On the occasion, I also want to invite all parties to increase cooperation in overcoming various health problems, so that all policies can support those problems," Health Minister Budi Gunadi Sadikin noted as written on Tuesday.
General Chairperson of the IDAI Central Management, Prof. Dr Aman Bhakti Pulungan, Sp.A, (K), FAAP, FRCPI (Hon.), stated that in 2018, the total population of children in Indonesia was estimated at 79 million. However, the IDAI noted that only 1,249 Indonesian children were diagnosed with T1DM during the 2017-2019 period.
"The treatment of type-1 diabetes must be comprehensive. One of the problems we face related to diabetes is data," he pointed out.
Related news: Expert outlines three symptoms of Type-2 diabetes
Along with Novo Nordisk, this collaboration will create a registration system through an application that will include a system of registration, education, treatment recommendations, and monitoring.
"I believe that if we can make a comprehensive application, Indonesia will be the first country to have the right system for children with T1DM and will help in every aspect of its management," he affirmed.
Novo Nordisk Indonesia and its global partners will work closely with the Ministry of Health and the IDAI to streamline components, such as upgrading existing health infrastructure; training and educating health workers; and diabetes educators.
Furthermore, the provision of blood glucose monitoring equipment and supplies; patient education for children and their families; patient registration system; and understanding and advocacy are the other components that will be improved.
Indonesia is the 16th nation to partake in a partnership with CDiC, according to the CDiC Steering Committee, Cem Ozenc.
"Through our partnership with the Ministry of Health and the IDAI, we will start reaching out to vulnerable children with type 1 diabetes throughout Indonesia," Vice President & General Manager of Novo Nordisk Indonesia Anand Shetty stated.
Related news: Health Ministry stresses regular health checks on World Diabetes Day
Related news: Indonesian university develops stem cell technique to cure diabetes
Translator: Arnidhya Nur, Raka Adji
Editor: Suharto
Copyright © ANTARA 2021
